The Latin America, Middle East and Africa RNA Analysis Market would witness market growth of 19.7% CAGR during the forecast period (2022-2028).
RNA-Seq is a sequencing method that makes use of next-generation sequencing (NGS) to examine the constantly changing cellular transcriptome to determine the presence and amount of RNA in a biological sample at any given time. With the use of RNA-Seq, it is now possible to examine alternative gene spliced transcripts, gene fusions, mutations and SNPs, post-transcriptional alterations, changes in gene expression over time, and variations in gene expression among groups and therapies.
Additionally, RNA-Seq could examine several RNA populations, such as small RNA, total RNA, and ribosome profiling. Exon/intron borders and previously defined 5' and 3' gene boundaries might also be determined using RNA-Seq. The next-generation sequencing method for analyzing viral genome variability includes NA isolation and enrichment. To keep RNA from deteriorating, biological materials are purified during the RNA separation process.
As one of the Middle East's most economically developed and diversified nations, the UAE has a strong healthcare system. The UAE government has prioritized creating world-class health systems, and as a result, the industry has developed and grown significantly over the past few years. After COVID-19 broke out in January 2020, the UAE government moved right away to implement preventative health measures. The UAE is regarded as one of the best countries in the world and the highest in the Arab world in terms of COVID-19 response due to the leadership's tireless efforts.
The Brazil market dominated the LAMEA RNA Analysis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $473.6 million by 2028. The Argentina market is experiencing a CAGR of 20.4% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 19.4% during (2022 - 2028).
Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology and Others. Based on End-use, the market is segmented into Government Institutes & Academic Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROs). Based on Application, the market is segmented into Infectious Diseases & Pathogenesis, Epigenetics, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics, Construction of RNA Expression Atlas, Alternative RNA Splicing and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global RNA Analysis Market is Predict to reach $28 Billion by 2028, at a CAGR of 15.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, Merck Group, and Promega Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Kits & Reagents
- Instruments
- Services
By Technology
- Real Time-PCR (qPCR) Technology
- Sequencing Technology
- Microarray Technology
- Others
By End-use
- Government Institutes & Academic Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
By Application
- Infectious Diseases & Pathogenesis
- Epigenetics
- RNA Structure & Molecular Dynamics
- Development & Delivery of RNA Therapeutics
- Construction of RNA Expression Atlas
- Alternative RNA Splicing
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific Group
- Merck Group
- Promega Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA RNA Analysis Market, by Product
1.4.2 LAMEA RNA Analysis Market, by Technology
1.4.3 LAMEA RNA Analysis Market, by End-use
1.4.4 LAMEA RNA Analysis Market, by Application
1.4.5 LAMEA RNA Analysis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players
Chapter 4. LAMEA RNA Analysis Market by Product
4.1 LAMEA Kits & Reagents Market by Country
4.2 LAMEA Instruments Market by Country
4.3 LAMEA Services Market by Country
Chapter 5. LAMEA RNA Analysis Market by Technology
5.1 LAMEA Real Time-PCR (qPCR) Technology Market by Country
5.2 LAMEA Sequencing Technology Market by Country
5.3 LAMEA Microarray Technology Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA RNA Analysis Market by End-use
6.1 LAMEA Government Institutes & Academic Centers Market by Country
6.2 LAMEA Hospitals & Clinics Market by Country
6.3 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
6.4 LAMEA Contract Research Organizations (CROs) Market by Country
Chapter 7. LAMEA RNA Analysis Market by Application
7.1 LAMEA Infectious Diseases & Pathogenesis Market by Country
7.2 LAMEA Epigenetics Market by Country
7.3 LAMEA RNA Structure & Molecular Dynamics Market by Country
7.4 LAMEA Development & Delivery of RNA Therapeutics Market by Country
7.5 LAMEA Construction of RNA Expression Atlas Market by Country
7.6 LAMEA Alternative RNA Splicing Market by Country
7.7 LAMEA Others Market by Country
Chapter 8. LAMEA RNA Analysis Market by Country
8.1 Brazil RNA Analysis Market
8.1.1 Brazil RNA Analysis Market by Product
8.1.2 Brazil RNA Analysis Market by Technology
8.1.3 Brazil RNA Analysis Market by End-use
8.1.4 Brazil RNA Analysis Market by Application
8.2 Argentina RNA Analysis Market
8.2.1 Argentina RNA Analysis Market by Product
8.2.2 Argentina RNA Analysis Market by Technology
8.2.3 Argentina RNA Analysis Market by End-use
8.2.4 Argentina RNA Analysis Market by Application
8.3 UAE RNA Analysis Market
8.3.1 UAE RNA Analysis Market by Product
8.3.2 UAE RNA Analysis Market by Technology
8.3.3 UAE RNA Analysis Market by End-use
8.3.4 UAE RNA Analysis Market by Application
8.4 Saudi Arabia RNA Analysis Market
8.4.1 Saudi Arabia RNA Analysis Market by Product
8.4.2 Saudi Arabia RNA Analysis Market by Technology
8.4.3 Saudi Arabia RNA Analysis Market by End-use
8.4.4 Saudi Arabia RNA Analysis Market by Application
8.5 South Africa RNA Analysis Market
8.5.1 South Africa RNA Analysis Market by Product
8.5.2 South Africa RNA Analysis Market by Technology
8.5.3 South Africa RNA Analysis Market by End-use
8.5.4 South Africa RNA Analysis Market by Application
8.6 Nigeria RNA Analysis Market
8.6.1 Nigeria RNA Analysis Market by Product
8.6.2 Nigeria RNA Analysis Market by Technology
8.6.3 Nigeria RNA Analysis Market by End-use
8.6.4 Nigeria RNA Analysis Market by Application
8.7 Rest of LAMEA RNA Analysis Market
8.7.1 Rest of LAMEA RNA Analysis Market by Product
8.7.2 Rest of LAMEA RNA Analysis Market by Technology
8.7.3 Rest of LAMEA RNA Analysis Market by End-use
8.7.4 Rest of LAMEA RNA Analysis Market by Application
Chapter 9. Company Profiles
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Qiagen N.V.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.9 Merck Group
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisition and Mergers:
9.10. Promega Corporation
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:
9.10.2.2 Geographical Expansions:
TABLE 1 LAMEA RNA Analysis Market, 2018 - 2021, USD Million
TABLE 2 LAMEA RNA Analysis Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– RNA Analysis Market
TABLE 4 Product Launches And Product Expansions– RNA Analysis Market
TABLE 5 Acquisition and Mergers– RNA Analysis Market
TABLE 6 Geographical Expansions – RNA Analysis Market
TABLE 7 LAMEA RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 8 LAMEA RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 9 LAMEA Kits & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Kits & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Services Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Services Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 16 LAMEA RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 17 LAMEA Real Time-PCR (qPCR) Technology Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Real Time-PCR (qPCR) Technology Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Sequencing Technology Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Sequencing Technology Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Microarray Technology Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Microarray Technology Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 26 LAMEA RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 27 LAMEA Government Institutes & Academic Centers Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Government Institutes & Academic Centers Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 36 LAMEA RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 37 LAMEA Infectious Diseases & Pathogenesis Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Infectious Diseases & Pathogenesis Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA RNA Structure & Molecular Dynamics Market by Country, 2018 - 2021, USD Million
TABLE 42 LAMEA RNA Structure & Molecular Dynamics Market by Country, 2022 - 2028, USD Million
TABLE 43 LAMEA Development & Delivery of RNA Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA Development & Delivery of RNA Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA Construction of RNA Expression Atlas Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA Construction of RNA Expression Atlas Market by Country, 2022 - 2028, USD Million
TABLE 47 LAMEA Alternative RNA Splicing Market by Country, 2018 - 2021, USD Million
TABLE 48 LAMEA Alternative RNA Splicing Market by Country, 2022 - 2028, USD Million
TABLE 49 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 50 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 51 LAMEA RNA Analysis Market by Country, 2018 - 2021, USD Million
TABLE 52 LAMEA RNA Analysis Market by Country, 2022 - 2028, USD Million
TABLE 53 Brazil RNA Analysis Market, 2018 - 2021, USD Million
TABLE 54 Brazil RNA Analysis Market, 2022 - 2028, USD Million
TABLE 55 Brazil RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 56 Brazil RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 57 Brazil RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 58 Brazil RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 59 Brazil RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 60 Brazil RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 61 Brazil RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 62 Brazil RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 63 Argentina RNA Analysis Market, 2018 - 2021, USD Million
TABLE 64 Argentina RNA Analysis Market, 2022 - 2028, USD Million
TABLE 65 Argentina RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 66 Argentina RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 67 Argentina RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 68 Argentina RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 69 Argentina RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 70 Argentina RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 71 Argentina RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 72 Argentina RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 73 UAE RNA Analysis Market, 2018 - 2021, USD Million
TABLE 74 UAE RNA Analysis Market, 2022 - 2028, USD Million
TABLE 75 UAE RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 76 UAE RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 77 UAE RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 78 UAE RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 79 UAE RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 80 UAE RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 81 UAE RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 82 UAE RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 83 Saudi Arabia RNA Analysis Market, 2018 - 2021, USD Million
TABLE 84 Saudi Arabia RNA Analysis Market, 2022 - 2028, USD Million
TABLE 85 Saudi Arabia RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 86 Saudi Arabia RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 87 Saudi Arabia RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 88 Saudi Arabia RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 89 Saudi Arabia RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 90 Saudi Arabia RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 91 Saudi Arabia RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 92 Saudi Arabia RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 93 South Africa RNA Analysis Market, 2018 - 2021, USD Million
TABLE 94 South Africa RNA Analysis Market, 2022 - 2028, USD Million
TABLE 95 South Africa RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 96 South Africa RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 97 South Africa RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 98 South Africa RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 99 South Africa RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 100 South Africa RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 101 South Africa RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 102 South Africa RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 103 Nigeria RNA Analysis Market, 2018 - 2021, USD Million
TABLE 104 Nigeria RNA Analysis Market, 2022 - 2028, USD Million
TABLE 105 Nigeria RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 106 Nigeria RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 107 Nigeria RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 108 Nigeria RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 109 Nigeria RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 110 Nigeria RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 111 Nigeria RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 112 Nigeria RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 113 Rest of LAMEA RNA Analysis Market, 2018 - 2021, USD Million
TABLE 114 Rest of LAMEA RNA Analysis Market, 2022 - 2028, USD Million
TABLE 115 Rest of LAMEA RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 116 Rest of LAMEA RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 117 Rest of LAMEA RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 118 Rest of LAMEA RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 119 Rest of LAMEA RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 120 Rest of LAMEA RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 121 Rest of LAMEA RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 122 Rest of LAMEA RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 123 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 124 Key Information – Danaher Corporation
TABLE 125 key Information – Agilent Technologies, Inc.
TABLE 126 Key Information – Thermo Fisher Scientific, Inc.
TABLE 127 Key Information – Qiagen N.V.
TABLE 128 key information – Illumina, Inc.
TABLE 129 Key Information – Bio-Rad Laboratories, Inc.
TABLE 130 Key Information – Eurofins Scientific Group
TABLE 131 key Information – Merck GrouP
TABLE 132 key Information – Promega Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche AG
FIG 6 Recent strategies and developments: Agilent Technologies, Inc.
FIG 7 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 8 Recent strategies and developments: Qiagen N.V.
FIG 9 Recent strategies and developments: Illumina, Inc.
FIG 10 Recent strategies and developments: Merck KGaA
FIG 11 Recent strategies and developments: Promega Corporation